Biovation II LLC – Boothbay, Maine
Biovation II LLC acquired in January 2010 as a spin-off from Rynel Inc., and is an innovator in advanced infection control solutions. The comapny’s areas of technical expertise includes bio-polymer based nonwovens, fibers, films, coatings and nano-materials, with proprietary silver-based technologies and manufacturing processes, which have been in development for over a decade. Biovation is a technology development and specialty manufacturing company.
Although the company is itself still a R&D facility, it has worldwide reputation and is on the cutting edge of the infection control industry. In testing, Biovation formulations consistently outperform other entries in the emerging infection control market. A major competitive strength of the Biovation team is its ability to create formulations to meet the unique needs of customers, optimizing both fast acting and long lasting properties. AAI brings strong complementary resources which assist the company in growing from a R&D consultancy status to a global sales and production oriented company.